LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 932974
BOSTON, MA
Position in AMLX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$32,381
+$7,320 QoQ
Shares Held
1,803
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#166
of 205 holders
Holding Since
Sep 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $1,097,583 across 5 Drug Manufacturers - Specialty & Generic names. AMLX ranks #4 (3.0% of the industry book) .
All Filings in AMLX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,381 | 1,803 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $25,061 | 1,803 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $21,780 | 1,803 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $24,502 | 1,803 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $11,557 | 1,803 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $6,382 | 1,803 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $6,815 | 1,803 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $5,841 | 1,803 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $3,425 | 1,803 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $5,120 | 1,803 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $26,540 | 1,803 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $33,012 | 1,803 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $38,890 | 1,803 | Shares | Sole | 2023-08-01 | |
| 2022-09-30 | $50,754 | 1,803 | Shares | Sole | 2022-10-25 | |
| No filing history on record for this holder in this stock. | ||||||